Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 1
2002 1
2003 1
2004 1
2007 1
2008 4
2009 2
2010 3
2011 1
2012 7
2013 5
2014 4
2015 10
2016 6
2017 8
2018 17
2019 15
2020 20
2021 25
2022 40
2023 31
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Cancer screening in China: a steep road from evidence to implementation.
Xia C, Basu P, Kramer BS, Li H, Qu C, Yu XQ, Canfell K, Qiao Y, Armstrong BK, Chen W. Xia C, et al. Lancet Public Health. 2023 Dec;8(12):e996-e1005. doi: 10.1016/S2468-2667(23)00186-X. Epub 2023 Nov 21. Lancet Public Health. 2023. PMID: 38000379 Free PMC article. Review.
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
Xu B, Tu S, Song L, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Fu X, Liu J, Zhao Y, Escaned J, Wang Y, Fearon WF, Dou K, Kirtane AJ, Wu Y, Serruys PW, Yang W, Wijns W, Guan C, Leon MB, Qiao S, Stone GW; FAVOR III China study group. Xu B, et al. Lancet. 2021 Dec 11;398(10317):2149-2159. doi: 10.1016/S0140-6736(21)02248-0. Epub 2021 Nov 4. Lancet. 2021. PMID: 34742368 Clinical Trial.
Delivery strategies in treatments of leukemia.
Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, Feng N, Gu Z. Ci T, et al. Chem Soc Rev. 2022 Mar 21;51(6):2121-2144. doi: 10.1039/d1cs00755f. Chem Soc Rev. 2022. PMID: 35188506 Review.
The application of Aptamer in biomarker discovery.
Li Y, Tam WW, Yu Y, Zhuo Z, Xue Z, Tsang C, Qiao X, Wang X, Wang W, Li Y, Tu Y, Gao Y. Li Y, et al. Biomark Res. 2023 Jul 19;11(1):70. doi: 10.1186/s40364-023-00510-8. Biomark Res. 2023. PMID: 37468977 Free PMC article. Review.
And as a multiplexed protein biomarker detection technology, aptamer-based SOMAScan can analyze thousands of proteins in a single run. In this review, we will introduce the principle and workflow of variations of SELEX-based methods, including secretome SELEX, ADAPT, Cell- …
And as a multiplexed protein biomarker detection technology, aptamer-based SOMAScan can analyze thousands of proteins in a single run …
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.
Wang T, Tang Y, Cai J, Wan X, Hu S, Lu X, Xie Z, Qiao X, Jiang H, Shao J, Yang F, Ren H, Cao Q, Qian J, Zhang J, An K, Wang J, Luo C, Liang H, Miao Y, Ma Y, Wang X, Ding L, Song L, He H, Shi W, Xiao P, Yang X, Yang J, Li W, Zhu Y, Wang N, Gu L, Chen Q, Tang J, Yang JJ, Cheng C, Leung W, Chen J, Lu J, Li B, Pui CH. Wang T, et al. J Clin Oncol. 2023 Mar 20;41(9):1670-1683. doi: 10.1200/JCO.22.01214. Epub 2022 Nov 8. J Clin Oncol. 2023. PMID: 36346962 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: This phase II trial enrolled 225 evaluable patients age 20 years between September 17, 2019, and December 31, 2021. We first conducted a safety run-in stage to determine the recommended dose. After interim analysis of the first 30 patients treated (27 …
PATIENTS AND METHODS: This phase II trial enrolled 225 evaluable patients age 20 years between September 17, 2019, and December 31, 2021. We …
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
Song L, Xu B, Tu S, Guan C, Jin Z, Yu B, Fu G, Zhou Y, Wang J, Chen Y, Pu J, Chen L, Qu X, Yang J, Liu X, Guo L, Shen C, Zhang Y, Zhang Q, Pan H, Zhang R, Liu J, Zhao Y, Wang Y, Dou K, Kirtane AJ, Wu Y, Wijns W, Yang W, Leon MB, Qiao S, Stone GW; FAVOR III China Study Group. Song L, et al. J Am Coll Cardiol. 2022 Nov 29;80(22):2089-2101. doi: 10.1016/j.jacc.2022.09.007. Epub 2022 Sep 19. J Am Coll Cardiol. 2022. PMID: 36424680 Free article. Clinical Trial.
196 results